ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue206,625102,81488,268160,880
Cost of Revenue----
Gross Profit206,625102,81488,268160,880
Operating Expenses
Research Development94,85657,45140,46123,189
Selling General and Administrative23,44120,74916,96613,543
Non Recurring----
Total Operating Expenses118,29778,20057,42736,732
Operating Income or Loss88,32824,61430,841124,148
Income from Continuing Operations
Total Other Income/Expenses Net4,7932,3331,7191,307
Earnings Before Interest and Taxes88,32824,61430,841124,148
Interest Expense----8
Income Before Tax93,12126,94732,560125,455
Income Tax Expense21,1659,23710,89446,463
Minority Interest----
Net Income From Continuing Ops71,95617,71021,66678,992
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income71,95617,71021,66678,992
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares71,95617,71021,66678,992